A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients

Clinical trial NCT00368706 · COMPLETED

Trial details

NCT number: NCT00368706
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder, Overactive

Start date: 2006-09-01
Primary completion: 2008-03-01
Enrollment: 246

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.